THE TALK: Gastrointestinal Cancers A Review of Data from the ESMO 2021 Virtual Meeting

home / the-talk / gastrointestinal-cancers-a-review-of-data-from-the-esmo-2021-virtual-meeting

Experts in gastric cancers review recent updates and data in gastrointestinal cancers presented at the ESMO 2021 Virtual Meeting.

Sponsored in part by Daiichi Sankyo. Content independently developed by OncLive.

EP. 1: ESMO 2021 Updates in Metastatic Esophageal Squamous Cell Carcinoma

By Sam Klempner, MD, Massachusetts General Hospital
Daniel H. Ahn, DO, Mayo Clinic

November 15th 2021

Experts in gastrointestinal cancers review recent updates and clinical implications from phase 3 trials presented at ESMO 2021 in metastatic esophageal squamous cell carcinoma (ESCC).

EP. 2: ESMO 2021 Updates in Gastroesophageal and Gastric Adenocarcinomas

By Sam Klempner, MD, Massachusetts General Hospital
Daniel H. Ahn, DO, Mayo Clinic

November 22nd 2021

Drs Sam Klempner, Nataliya V. Uboha, Daniel H. Ahn, and Manish A. Shah discuss recent data presented at ESMO 2021 for metastatic or locally advanced gastroesophageal and gastric adenocarcinomas.

EP. 3: ESMO 2021 Updates in HER2+ Metastatic Gastric and Gastroesophageal Cancer

By Sam Klempner, MD, Massachusetts General Hospital
Daniel H. Ahn, DO, Mayo Clinic

November 29th 2021

Key opinion leaders in gastric cancers comment on ESMO 2021 updates in metastatic HER2+ esophagogastric adenocarcinoma and metastatic HER2+ gastric or gastroesophageal junction cancer.

EP. 4: ESMO 2021 Updates in Gastric Cancer and Colorectal Cancer

By Sam Klempner, MD, Massachusetts General Hospital
Daniel H. Ahn, DO, Mayo Clinic

December 6th 2021

Sam Klempner, MD; Daniel H. Ahn, DO; Nataliya V. Uboha, MD, PhD; and Manish A. Shah, MD, FASCO, review recent updates in second-line gastric cancer, CAR T-cell therapy in solid tumors, and colorectal cancer presented at ESMO 2021.